Evidence map›Paper›PMID 33181839›Full record

ArticleRadiation research2021

Radiation Risk of Ovarian Cancer in Atomic Bomb Survivors: 1958-2009.

Mai Utada, Alina V Brenner, Dale L Preston, John B Cologne, Ritsu Sakata, Hiromi Sugiyama, Naohiro Kato, Eric J Grant, Elizabeth K Cahoon, Kiyohiko Mabuchi and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Radiation research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Global epidemiology of epithelial ovarian cancer.Nature reviews. Clinical oncology · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Mai UtadaRadiation Effects Research Foundation, Hiroshima and Nagasaki, Japan.
Alina V BrennerRadiation Effects Research Foundation, Hiroshima and Nagasaki, Japan.
Dale L PrestonHirosoft International, Eureka, California.
John B CologneRadiation Effects Research Foundation, Hiroshima and Nagasaki, Japan.
Ritsu SakataRadiation Effects Research Foundation, Hiroshima and Nagasaki, Japan.
Hiromi SugiyamaRadiation Effects Research Foundation, Hiroshima and Nagasaki, Japan.
Naohiro KatoRadiation Effects Research Foundation, Hiroshima and Nagasaki, Japan.
Eric J GrantRadiation Effects Research Foundation, Hiroshima and Nagasaki, Japan.
Elizabeth K CahoonDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland.
Kiyohiko MabuchiDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland.
Kotaro OzasaRadiation Effects Research Foundation, Hiroshima and Nagasaki, Japan.
Radiation Effects Research Foundation · JPNational Cancer Institute · US

Funding

Studies of Populations Exposed to Environmental Sources of RadiationZIACP010132 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI CAHOON, ELIZABETH · 2009 to 2025
$35.2M
Studies of Atomic Bomb SurvivorsZIACP010134 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI CAHOON, ELIZABETH · 2009 to 2020
$4.8M
Intramural NIH HHS ZIA CP010134NCI NIH HHS HHSN261201400009C
6 · The paper itself

Abstract

There is limited evidence concerning the association between radiation exposure and ovarian cancer. We evaluated radiation risk of ovarian cancer between 1958 and 2009 among 62,534 female atomic bomb survivors in the Life Span Study cohort, adding 11 years of follow-up from the previously reported study. Poisson regression methods were used to estimate excess relative risk per Gy (ERR/Gy) for total ovarian cancer and according to tumor type. We assessed the modifying effect of follow-up period and other factors on the radiation risk. We ascertained 288 first primary ovarian cancers including 77 type 1 epithelial cancers, 75 type 2 epithelial cancers, 66 epithelial cancers of undetermined type and 70 other cancers. Radiation dose was positively, although not significantly, associated with risk of total ovarian cancer [ERR/Gy = 0.30, 95% confidence interval (CI): -0.22 to 1.11]. There was a suggestion of heterogeneity in radiation effects (P = 0.08) for type 1 (ERR/Gy = -0.32, 95% CI: <-0.32 to 0.88) and type 2 cancers (ERR/Gy = 1.24, 95% CI: -0.08 to 4.16). There were no significant trends in the ERR with time since exposure or age at exposure. Further follow-up will help characterize more accurately the patterns of radiation risk for total ovarian cancer and its types.

Indexed as

AdolescentAdultAtomic Bomb SurvivorsChildChild, PreschoolCohort StudiesFemaleHumansInfantJapanLongevityMiddle AgedNeoplasms, Radiation-InducedNuclear WeaponsOvarian NeoplasmsRadiation Exposure

Identifiers

PMID33181839
PMCPMC10320731
OpenAlexW3103371619

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.